Dow Up 0.76% Nasdaq Up 0.69%

Geron Corporation (GERN)

-NasdaqGS
2.23 Up 0.02(0.90%) 4:00PM EDT
Prev Close:2.21
Open:2.20
Bid:2.11 x 200
Ask:2.30 x 200
1y Target Est:4.13
Beta:2.3
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:2.17 - 2.24
52wk Range:1.31 - 7.36
Volume:1,661,606
Avg Vol (3m):1,999,190
Market Cap:349.85M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNUp 0.90%349.85M
BMYUp 2.15%88.91B
GSKUp 0.95%109.99B
NVSUp 1.02%218.72B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):283.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.23
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-1.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback